MaxCyte, Inc. (MXCT)
$1.01-0.98%Close
SELLCRISIS · day 7
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $108M
- Beta
- 1.53
- P/E (TTM)
- -3.26
- Short % float
- 1.12%
- Days to cover
- 3.1
- SI change
- -6.9%
- 1W
- -5.61%
- 1M
- -15.13%
- vs SPY 1W
- -6.77%
- vs SPY 1M
- -18.12%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on MXCT?
- LOPJLB’s latest quantitative signal on MaxCyte, Inc. (MXCT) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is MXCT in?
- MaxCyte, Inc. (MXCT) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does MaxCyte, Inc. (MXCT) do?
- MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-…